Active-ingredient Dossier
Lansoprazole
Active-ingredient Dossier for Lansoprazole (proton pump inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: ZOTON FasTabs
- Brand: APO-LANSOPRAZOLE
- Brand: APO-LANSOPRAZOLE ODT
- Brand: LANSOPRAZOLE ODT
- Brand: LANZOPRAN
- Therapeutic area: Gastroenterology
What is
Lansoprazole Lansoprazole is a proton pump inhibitor.
Australian brands containing
Lansoprazole — ZOPRAL — ZOTON FasTabs — APO-LANSOPRAZOLE — APO-LANSOPRAZOLE ODT — LANSOPRAZOLE ODT — LANZOPRAN
Therapeutic areas
Lansoprazole is registered in Infectious Disease, with 6 brands containing the ingredient.
Sponsor landscape
Lansoprazole is marketed by five sponsors: Lupin, Arrotex Pharmaceuticals, Sun Pharma, Alphapharm, and Pfizer.
PBS and regulatory activity
Two brands containing lansoprazole have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 November 2017, with one brand having PBAC outcomes recorded. No AusPARs are on record for lansoprazole.